A review of the safety of intravenous drug delivery systems

Hospital Pharmacy

Volumn 34, Issue 9, 1999, Pages 1044-1056

  Schneider, Philip J ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISEPSIS; COST EFFECTIVENESS ANALYSIS; DRUG MIXTURE; ERROR; EVALUATION; HEALTH CARE COST; HUMAN; INFUSION PUMP; INTRAVENOUS DRUG ADMINISTRATION; REVIEW; SAFETY;

EID: 0033495348     PISSN: 00185787     EISSN: None     Source Type: Journal    
DOI: 10.1177/001857879903400906     Document Type: Review

References (31)

1. Rapp RP. Considering product features and costs in selecting a system for intermit-tent IV drug delivery. Am J Hasp Pharm. 1987:44:2533-8.
2. Patterson TR, Nordstrom KA.An analysis of IV additive procedures on nursing units. Am J Hasp Pharm. 1968; 25:134-7.
3. Thur MP, Miller WA and Latiolais CJ. Medication errors in a nurse-controlled parenteral admixture program. Am J Hasp Pharm. 1972;29:298-304.
4. O'Hare MCB, Bradley AM, Gallagher T et al. Errors in administration of intravenous drugs. Br Med J. 1995:310:1536-7.
5. Thomson WL, Peer TD. Incomplete mixing of drugs in intravenous solutions. Crit Care Meet. 1980;8:603-7.
6. Perlstein PH, Callison C, White M et al. Errors in drug computations during newborn intensive care. Am J Dis Child. 1979:133:376-9.
7. Flynn EA, Pearson RE, Barker KN. Observational study of accuracy in compounding i.v. admixtures at five hospitals. Am J Hcaltb-Syst Pharm. 1997:54:904-12.
8. Miller WA, Smith GL, Latiolais CJ. A comparative evaluation of compounding costs and contamination rates of intravenous admixture systems. Drug Intell Clin Pharm. 1971:5:51-60.
9. Sanders LH, Mabadeje SA, Avis KE et al. Evaluation of compounding accuracy and aseptic technique for intravenous admixtures.Am J Hosp Pharm. 1978:35:531-6.
10. Brier KI, Latiolais CJ, Schneider PJ, et al. Effect of laminar airflow and clean room dress on contamination rates of intravenous admixtures. Am J Hasp Pharm. 1981;38:1144-7.
11. Letcher KI, Thnipp LD, Schapiro DJ, et al. In-use contamination of intravenous solutions in flexible plastic containers. Am J Hosp Pharm. 1972;29:673-7.
12. Allinson RR, Stach PE, Sherrin TE, et al. Compounding times and contamination rates associated with the preparation of intravenous admixtures in three types of plastic containers. Am J Hasp Pharm. 1979:36:513-7.
13. Paxinos J, Hammel RJ, Fritz WL. Contamination rates and costs associated with the use of four intermittent intravenous infusion systems. Am J Hasp Pharm. 1979; 36:1497-1503.
14. Luff RD, Roberts RJ. Methods for intravenous drug administration in the pediatric patient. J Ped. 1981;98:631-5.
15. Nahata MC, Powell DA, Durrell DE, et al. Effect of infusion method on tobramycin serum concentrations in newborn infants. J Ped. 1984;104:136-8.
16. Rajchgot P.Radde IC,MacLeod SM. Influence of specific gravity on intravenous drug delivery J Ped. 1981 ;99:658-61.
17. Leff RD, Johnson GF, Ercnberg A, et al. Evaluation of an extension set for intermittent intravenous drug delivery to infants. Am J Hasp Pharm. 1985;42:1358-62.
18. Loeb AJ, Fishman DA, Kochis TR. Premixed intravenous admixtures: A critical challenge for hospital pharmacy.Am J Hosp Pharm. 1983;40:104l-3.
19. Lee HE. Premixed intravenous admixtures: A positive development for hospital pharmacy. Am J Hasp Pharm. 1983; 40:1043-4.
20. Rapp RP. Hospital intravenous drug administration in the era of prospective payment. Drug Intell Clin Pharm. 1985; 19:146-8.
21. Salberg DS, Newton RW, Leduc DT. Cost of wastage in a hospital intravenous admixture program. Hasp Form. 1984;19:375-8.
22. Adachi WD, Endo AY.Tanaka JY. Controlling admixture waste through pharmacist monitoring. Am J Hosp Pharm. 1984; 41:883-
23. Vogel DP, Eck TA, Witte KW. Calculation of product waste in i.V. admixture programs. Am J Hasp Pharm. 1986;43:952-3.
24. Witte KW, Eck TA, Vogel DP. Decision analysis applied to the purchase of frozen premixed intravenous admixtures. Am J Hasp Pharm. 1985;42:835-9.
25. Smith TF, Kitrenos, JG. Comparison of seven methods of preparing and administering cefazolin sodium small volume parenterals. Am J Hasp Pharm. 1986; 43:1930-5.
26. Smith CF.Amen RJ. Comparison of seven methods of preparing and administering small volume parcnterals. Am J Hosp Pharm. 1988;45:1896-901.
27. Dasta JF, Bonfiglio MF, Rngue NG, et al. Accuracy and variability of intravenous theophylline preparations. Tber Drug Monit. 1990;12:554-7.
28. Recommended standards of practice, policies, and procedures for intravenous therapy. Am J Hosp Pharm. 1980;37:660-3.
29. Recommendations to pharmacists for solving problems with large volume parenterals-1979. Am J Hosp Pharm. 1980;37:663-7.
30. Recommended guidelines for quality assurance in hospital centralized intravenous admixture services. Am J Hosp Pharm. 1980;37:645-55.
31. ASHP technical assistance bulletin on quality assurance for pharmacy prepared sterile products. Am J Hosp Pharm. 1993:50:2386-98.